| Year |
Citation |
Score |
| 2022 |
Moonen JR, Chappell J, Shi M, Shinohara T, Li D, Mumbach MR, Zhang F, Nair RV, Nasser J, Mai DH, Taylor S, Wang L, Metzger RJ, Chang HY, Engreitz JM, et al. KLF4 recruits SWI/SNF to increase chromatin accessibility and reprogram the endothelial enhancer landscape under laminar shear stress. Nature Communications. 13: 4941. PMID 35999210 DOI: 10.1038/s41467-022-32566-9 |
0.4 |
|
| 2021 |
Kim DS, Risca VI, Reynolds DL, Chappell J, Rubin AJ, Jung N, Donohue LKH, Lopez-Pajares V, Kathiria A, Shi M, Zhao Z, Deep H, Sharmin M, Rao D, Lin S, et al. The dynamic, combinatorial cis-regulatory lexicon of epidermal differentiation. Nature Genetics. PMID 34650237 DOI: 10.1038/s41588-021-00947-3 |
0.334 |
|
| 2020 |
Hennigs JK, Cao A, Li CG, Shi M, Mienert J, Miyagawa K, Körbelin J, Marciano DP, Chen PI, Roughley M, Elliott MV, Harper RL, Bill MA, Chappell J, Moonen JR, et al. PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension. Circulation Research. PMID 33322916 DOI: 10.1161/CIRCRESAHA.119.316339 |
0.653 |
|
| 2020 |
van der Feen DE, Bossers GPL, Hagdorn QAJ, Moonen JR, Kurakula K, Szulcek R, Chappell J, Vallania F, Donato M, Kok K, Kohli JS, Petersen AH, van Leusden T, Demaria M, Goumans MTH, et al. Cellular senescence impairs the reversibility of pulmonary arterial hypertension. Science Translational Medicine. 12. PMID 32727916 DOI: 10.1126/Scitranslmed.Aaw4974 |
0.437 |
|
| 2019 |
Tian W, Jiang X, Sung YK, Shuffle E, Wu TH, Kao PN, Tu AB, Dorfmüller P, Cao A, Wang L, Peng G, Kim Y, Zhang P, Chappell J, Pasupneti S, et al. Phenotypically-Silent Bone Morphogenetic Protein Receptor 2 (Bmpr2) Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing The Risk for Neointimal Transformation. Circulation. PMID 31462075 DOI: 10.1161/Circulationaha.119.040629 |
0.538 |
|
| 2017 |
Sailani MR, Chappell J, Inlora J, Lynch L, Narasimha A, Mazroui S, Zia A, Bernstein J, Aryani O, Snyder MP. WISP3 mutation associated with Pseudorheumatoid Dysplasia. Cold Spring Harbor Molecular Case Studies. PMID 29092958 DOI: 10.1101/mcs.a001990 |
0.541 |
|
| 2016 |
Gu M, Shao NY, Sa S, Li D, Termglinchan V, Ameen M, Karakikes I, Sosa G, Grubert F, Lee J, Cao A, Taylor S, Ma Y, Zhao Z, Chappell J, et al. Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers. Cell Stem Cell. PMID 28017794 DOI: 10.1016/J.Stem.2016.08.019 |
0.692 |
|
| 2016 |
Sa S, Gu M, Chappell J, Shao NY, Ameen M, Elliott KA, Li D, Grubert F, Li CG, Taylor S, Cao A, Ma Y, Fong R, Nguyen L, Wu JC, et al. iPSC Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity. American Journal of Respiratory and Critical Care Medicine. PMID 27779452 DOI: 10.1164/Rccm.201606-1200Oc |
0.665 |
|
| 2013 |
Singh AM, Chappell J, Trost R, Lin L, Wang T, Tang J, Matlock BK, Weller KP, Wu H, Zhao S, Jin P, Dalton S. Cell-cycle control of developmentally regulated transcription factors accounts for heterogeneity in human pluripotent cells. Stem Cell Reports. 1: 532-44. PMID 24371808 DOI: 10.1016/J.Stemcr.2013.10.009 |
0.335 |
|
| 2013 |
Chappell J, Dalton S. Roles for MYC in the establishment and maintenance of pluripotency. Cold Spring Harbor Perspectives in Medicine. 3: a014381. PMID 24296349 DOI: 10.1101/Cshperspect.A014381 |
0.331 |
|
| Show low-probability matches. |